Articles related to MEDICAL DEVICES

Recordings from four Parkinson’s disease patients linked cuneiform and pedunculopontine nuclei activity to distinct phases of gait initiation. Freezing episodes were preceded by disrupted mesencephalic timing, though clinical translation remains early.

The NAUTILUS trial met its primary safety endpoint for responsive centromedian thalamic stimulation in drug-resistant idiopathic generalized epilepsy. The prespecified primary effectiveness endpoint was not significant, while post hoc and 18-month outcomes showed sustained seizure reductions.

A prototype wearable ring continuously monitored multiple sweat biomarkers, including glucose and ketones, in healthy volunteers and individuals with type 1 diabetes. The device’s readings tracked established monitoring technologies, though larger validation studies remain necessary.

A joint epilepsy society position statement endorsed validated noninvasive seizure detection and alerting devices as part of individualized epilepsy care while emphasizing their strongest performance in tonic-clonic seizures and the absence of proven SUDEP prevention.

The FDA cleared the Dexcom Stelo Glucose Biosensor System for over-the-counter use in children ages 2 and older who do not use insulin, expanding a device previously limited to adults and supporting caregiver-supervised home glucose monitoring.

An interventional cardiologist at UCLA Health describes how combined IVUS and near-infrared spectroscopy imaging identified culprit lesions in angiographically ambiguous NSTEMI cases and informed stent landing zone decisions in complex PCI.